First Trust IPOX Europe Equity Opportunities UCITS ETF

First Trust IPOX Europe Equity Opportunities UCITS ETF

ETF · IE00BFD26097 (XLON)
Overview
AI-Powered Analysis
Fundamental Analysis
Find out what the numbers really say — before the market does
Analyze now
News Sentiment
Are today's headlines a buy signal or a red flag?
Analyze now
Buy / Hold / Sell
Should you Buy, Hold, or Sell? Get the AI verdict now.
Analyze now
Risk Assessment
Uncover hidden risks before they hit your portfolio.
Analyze now
Fair Value
Is this stock cheap, fairly priced, or overvalued?
Analyze now
Latest AI Analyses of First Trust IPOX Europe Equity Opportunities UCITS ETF
No Price
Closing Price XLON 29.04.2026: 2.110,00 GBX
29.04.2026 07:03
Current Prices from First Trust IPOX Europe Equity Opportunities UCITS ETF
ExchangeTickerCurrencyLast TradePriceDaily Change
XLON: London
London
FPXE.L
GBX
29.04.2026 07:03
2.110,00 GBX
4,00 GBX
+0,19 %
XHAM: Hamburg
Hamburg
FTIPOX97.HAMB
EUR
29.04.2026 06:10
24,31 EUR
-
XLON: London
London
IPXE.L
USD
28.04.2026 16:15
28,45 USD
-0,50 USD
-1,74 %
Company Profile for First Trust IPOX Europe Equity Opportunities UCITS ETF ETF
This exchange-traded fund seeks investment results that correspond generally to the price and yield (before the funds fees and expenses) of an equity index called the IPOX 100 Europe Index.

Company Data

Name First Trust IPOX Europe Equity Opportunities UCITS ETF
Company First Trust IPOX Europe Equity Opportunities UCITS ETF
Website https://www.ftglobalportfolios.com/uk/retail/Products/IPOX-Europe-Equity-Opportunities/
Primary Exchange XLON London
ISIN IE00BFD26097
Asset Class ETF
Sector Financial Services
Industry Asset Management
Country Ireland
Currency GBX
Employees -
IPO Date 2021-06-22

Ticker Symbols

Name Symbol
Hamburg FTIPOX97.HAMB
London IPXE.L
London FPXE.L
More Shares
Investors who hold First Trust IPOX Europe Equity Opportunities UCITS ETF also have the following shares in their portfolio:
RANDSTAD NV EO -,10
RANDSTAD NV EO -,10 Share
XPHYTO THERAPEUTICSCS
XPHYTO THERAPEUTICSCS Share